Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

9.94
Delayed Data
As of Aug 25
 -0.05 / -0.50%
Today’s Change
9.23
Today|||52-Week Range
55.47
-72.68%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close9.99
Today’s open10.06
Day’s range9.78 - 10.33
Volume373,572
Average volume (3 months)552,756
Market cap$289.4M
Dividend yield--
Data as of 08/25/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-116.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
CRVSCorvus Pharmaceutica...+0.19+1.39%
COCPCocrystal Pharma Inc+0.01+1.75%
ADMSAdamas Pharmaceutica...-0.41-2.99%
AKBAAkebia Therapeutics ...+0.06+0.75%
Data as of 3:02pm ET, 08/25/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

Partner Offers

Search for Jobs